Polymyxin B-Associated Muscle Injury: A Case Report. [PDF]
Lei W +5 more
europepmc +1 more source
Risk of Permanent Dental Staining Following Exposure to Newer-Generation Tetracycline Derivatives in Children: A Systematic Review and Meta-Analysis. [PDF]
Machuca-Portillo C +6 more
europepmc +1 more source
Use of Tigecycline for Diabetic Foot Infections
Objective. The aim of this study is to evaluate tigecycline for diabetic foot infections (DFIs). Materials and Methods. In this prospective observational study, the investigators included patients who had consultation with the Diabetic Foot Council of ...
Uysal, Serhat +7 more
core
<i>In vitro</i> activity of ceftaroline against clinical isolates of Gram-positive bacteria in paediatric patients: ATLAS programme 2018-2023. [PDF]
Kiratisin P +3 more
europepmc +1 more source
Longitudinal Antimicrobial Susceptibility Shifts in Environmental <i>Legionella pneumophila</i> from a Drinking Water Distribution System. [PDF]
Madagi L +4 more
europepmc +1 more source
Risk factors for tigecycline-associated drug-induced liver injury in critically Ill patients: a 2020-2023 retrospective study from a Chinese hospital. [PDF]
Wang Y, Zhang S, Shen M, Zhang K.
europepmc +1 more source
Outcome of Ceftazidime/Avibactam Versus Alternative Antibiotics for Treatment of Carbapenem-Resistant <i>Enterobacterales</i> Bacteremia in Patients With Hematologic Malignancies. [PDF]
Jang HM +9 more
europepmc +1 more source
Evaluation of Oxford nanopore sequencing for antimicrobial resistance surveillance in <i>Salmonella</i>: comparison with phenotypic antimicrobial susceptibility in a large-scale study. [PDF]
Hong Y-P +8 more
europepmc +1 more source
Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort. [PDF]
Huang YT +4 more
europepmc +1 more source
Case Report: A case of carbapenem hypersensitivity and tigecycline-associated coagulopathy after immunotherapy for advanced oral cancer. [PDF]
Peng Y, Peng R.
europepmc +1 more source

